Subscribe

Anne Runyan, Two Labs Pharma Services

Articles by Anne Runyan, Two Labs Pharma Services

Innovative models to address cell- and gene-therapy (CGT) payer challenges

ByAnne Runyan, Two Labs Pharma Services

May 1st 2020

Carving out CGTs for payment systems involving government intervention may be an answer

Latest Updated Articles

Innovative models to address cell- and gene-therapy (CGT) payer challenges
Published: May 1st 2020 | Updated:

Trending on Pharmaceutical Commerce

TrumpRx Launches With MFN-Based Drug Discounts

Pharma's Year of Two Halves

FTC–Express Scripts Settlement Targets PBM Rebates, Transparency, and Patient Drug Costs

The Great Repricing: Commercial Channel Under Pressure

Your Copay Program Is Protecting Access. Is It Also Protecting Gross-to-Net?